ESCRS - New multifocal IOLs

New multifocal IOLs

New multifocal IOLs

Abbott has announced the European launch of two new measurements (optical add powers) for the TECNIS® Multifocal intraocular lens (IOL), which the company says will provide more customised treatment options for cataract patients. “With the addition of these TECNIS Multifocal IOLs, Abbott is able to provide physicians the ability to offer a more precise lens option for their patients, allowing them to maintain quality vision at near, intermediate and far distances,” said a company spokesman. “The TECNIS Multifocal +2.75 add power IOL is suited for patients who prefer intermediate vision activities, such as seeing an automobile dashboard. The TECNIS Multifocal +3.25 add power IOL is suited for patients favouring activities at longer reading distances such as working at a computer, while still providing a full range of vision,” he said.

 www.abbott.com

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...